Thetford Mines, Quebec - TheNewswire – July 29, 2021 – KDA Group Inc. (TSXV:KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) are pleased to announce an update on the Elixir 420 software platform (the “Elixir 420 Software Platform”).

Tech KDA is working to complete the development of Elixir 420 Software Platform, its medical cannabis platform to be able to do a commercial launch this fall.

Elixir 420 Software Platform is an innovative health network platform of e-Prescribing for medical cannabis, the world’s first patient-centric health ecosystem addressing THC/CBD.

A nightly dose of medicinal cannabis (MC) improved sleep and other quality of life (QOL) outcomes in patients with high-grade gliomas, according to results of a study published in Frontiers in Oncology.

Researchers conducted a randomized, phase 2 trial comparing 2 ratios of oral MC oil in patients diagnosed with recurrent or inoperable high-grade gliomas, including glioblastoma multiforme and grade III anaplastic astrocytoma.

The study enrolled 88 patients. Their average age was 53.3 years, a majority of patients were White (95.2%), and about half were women (49.4%).

Darren McCarty said he wouldn't be alive today if he never found marijuana.

The former NHL star and four-time Stanley Cup champion balanced a 16-year hockey career with binge drinking and alcoholism, McCarty told Insider in an interview. But once he retired in 2009, there was no sport left to balance out his addiction, and his drinking habits escalated to life-threatening levels over the next six years.

"I was 280 pounds," McCarty said. "My blood pressure when I was in the hospital was 265 over 145. I should be dead."

A proprietary hemp extract shows promise as a supplement to help promote weight loss, according to research funded by a grant from the National Institutes of Health. Data from the double-blind, placebo-controlled study showed that all 100 participants who took Nitro-V hemp extract daily lost weight, shedding up to 22 pounds over a 90 days. The minimum weight loss for those taking the supplement was five pounds, while 64% of participants in the placebo group either gained weight or saw no change.

If you’re one of the millions of people who have trouble sleeping, you may have considered a cannabis compound, such as CBD. Some say cannabis compounds are helpful, but more research is needed. And they might not be legal, depending on where you live. Look up the laws to know what’s allowed.

U.S. researchers acknowledge that new study results should not be considered irrefutable, but they still offer some guidance about whether or not men should be consuming cannabis if trying to start a family.

Noting that cannabis consumption is common among men presenting for a fertility evaluation, the investigators suggest using weed “may have a detrimental effect on semen quality, particularly morphology and volume.”

Misinformation has run rampant over the use of marijuana for decades. In 1936, the church group-financed movie Reefer Madness taught the public about the perils presented in using the drug — everything from attempted murder to suicide and madness. Around the same time, Harry Anslinger and others began the war on drugs, which was at least partly fueled by racist motives.

It’s understandably difficult for most people to make an informed decision about whether marijuana is the next medical breakthrough or another ill-fated attempt at a silver bullet.

By Dr. Mark Calarco, National Medical Director for Clinical Diagnostics at American Addiction Centers.

Increasing Use of Medical Marijuana to Alleviate Symptoms, Treat Diseases and Conditions and in Pain Management are Key Factor Driving Industry Growth, says Emergen Research

VANCOUVER, BC, July 26, 2021 /PRNewswire/ — The global medical cannabis market size is expected to reach USD 47.15 billion in 2027 at a CAGR of 16.9%, according to the latest report by Emergen Research. Market revenue growth can be attributed to the increasing use of medical cannabis to treat diseases and conditions, rising research and development activities, and legalization of cannabis in various countries across the globe. Increasing government initiatives to encourage safe usage and consumption of the product is also a key factor expected to contribute to market growth over the forecast period.  

Canadian cannabis companies have been on the rise recently, and part of that wave includes High Tide, Inc. (High Tide Stock Quote, Chart, News, Analysts, Financials TSXV:HITI). Andrew Semple of Echelon Capital Markets Tuesday reiterated his “Speculative Buy” rating on the company, along with a $20.00/share target price, implying a potential upside of 150 per cent in the next 12 months.